Muhammad Aasim Ali: Treatment Strategies for Chemotherapy-Induced Cytopenias
Muhammad Aasim Ali, Pharmacist at Premium Care Medical Polyclinic, shared a post on LinkedIn:
”Cancer Myelosuppression Treatment
Cancer therapy–induced myelosuppression:
Neutropenia:
Granulocyte colony-stimulating factors include:
- filgrastim
- pegfilgrastim
They act on myeloid progenitors via the G-CSF receptor to accelerate neutrophil proliferation, differentiation, and release from the bone marrow.
Pegylation prolongs half-life and allows once-per-cycle dosing.
These agents reduce febrile neutropenia risk but can cause bone pain and, rarely, splenic complications.
Anemia:
Chemotherapy-induced anemia is addressed with erythropoiesis-stimulating agents such as:
- epoetin alfa
- darbepoetin alfa
These drugs activate erythropoietin receptors on erythroid progenitors to increase erythrocyte production.
However, their use is restricted due to risks of thromboembolism and potential tumor progression, and they are generally reserved for palliative settings with careful hemoglobin targets.
Thrombocytopenia:
- Oprelvekin: a recombinant human IL-11 drug used to prevent severe thrombocytopenia and reduce the need for platelet transfusions.
It acts as a thrombopoietic growth factor that stimulates the bone marrow to produce more megakaryocytes and platelets.”
Stay updated with Hemostasis Today.
-
May 9, 2026, 16:38Joseph R. Shaw: Risk Stratification is Only Useful if It is Practical, Consistent, and Easy to Apply at the Bedside
-
May 9, 2026, 16:11Milad Abdalla: When 180,000 Becomes 45,000 – The EDTA Trap
-
May 9, 2026, 16:10Gertrud U. Rey: Describing the Mechanism That Causes VITT
-
May 9, 2026, 16:09Dima Shulkin: The Earliest Warning Sign of a Severe Heart Attack May Already Be in the CBC
-
May 9, 2026, 16:08Luisanna M. Sánchez: Selected for the ASH Clinical Research Training Institute
-
May 9, 2026, 16:07Maha Othman: Key Highlights from Southern Ontario Reproductive Biology
-
May 9, 2026, 15:36Rami Z. Morsi: Advancing the Full Spectrum of Stroke Care at UCM 2026 3rd Annual Stroke Symposium
-
May 9, 2026, 15:34Recognizing the Essential Role of Psychosocial Care within Bleeding Disorders Care – EAHAD
-
May 9, 2026, 15:27Abdulrahman Nasiri: How AI and Deep Learning May Help Reshape the Future of Thalassaemia Care